TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) Files An 8-K Results of Operations and Financial Condition

TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) Files An 8-K Results of Operations and Financial Condition

Story continues below

Item 2.02.Results of Operations and Financial Condition.

On February 27, 2017 we issued a press release disclosing our
results of operations and financial condition for our most
recently completed fiscal quarter and fiscal year.In accordance
with General Instruction B.2 of Form 8-K, the information in this
Current Report on Form 8-K, including Exhibit 99, shall not be
deemed to be filed for purposes of Section 18 of the Securities
Exchange Act of 1934 or otherwise subject to the liability of
that section, and shall not be incorporated by reference into any
registration statement or other document filed under the
Securities Act of 1933 or the Securities Exchange Act of 1934,
except as shall be expressly set forth by specific reference in
that filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.

Description

99.1

Press Release dated February 27, 2017


About TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD)

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) Recent Trading Information

TACTILE SYSTEMS TECHNOLOGY, INC. (NASDAQ:TCMD) closed its last trading session up +0.07 at 17.26 with 22,824 shares trading hands.

An ad to help with our costs